Class I — Most Severe

Total Nutrition Recalls Organic Moringa for Salmonella Risk

FreshRecall Team Total Nutrition Inc. Salmonella
Share

Class I Recall — Most Serious

This is a Class I recall — the most serious type. Products covered by this recall may cause serious health consequences or death.

TN Organic Moringa Capsules Front - Lot 2800 Exp 2-2028 TN Organic Moringa Powder Front- Lot 2782 Exp 5-2028 TN Organic Moringa Powder Side - Lot 2782 Exp 5-2028 TN Organic Moringa Capsules Bottom - Lot 2800 Exp 2-2028

Total Nutrition Inc. is recalling its TNVitamins 100% Organic Moringa Capsules and Powder due to potential Salmonella contamination. This recall follows a supplier-initiated recall of the raw Organic Moringa ingredient.

Products Affected:

  • TNVitamins 100% Organic Moringa Capsules 1,200 mg, Lot #: 2800, Exp: 2/2028
  • TNVitamins 100% Organic Moringa Powder, Lot #: 2782, Exp: 5/2028

The lot numbers can be found on the bottom of the bottle or near the barcode on the label. These products were sold online through platforms such as Amazon, Walmart, TikTok Shop, and Target, as well as on the company's website.

Reason for Recall:

The recall is due to the potential presence of Salmonella, which can cause serious infections, especially in young children, the elderly, and those with weakened immune systems. Symptoms may include fever, diarrhea, nausea, vomiting, and abdominal pain.

What Consumers Should Do:

Customers are advised to dispose of the affected products immediately. Do not consume, sell, or serve these products. For further information, visit tnvitamins.com or contact customer service at [email protected].

No illnesses have been reported to date. Total Nutrition Inc. is committed to ensuring the quality and safety of its products.

Affected Products

Product Name Lot Number Expiration Date
AB9917 Lot #: 2800 Exp: 2/2028
AB9904 Lot #: 2782 Exp: 5/2028

Where Products Were Sold

This recall affects products distributed nationwide across the United States.

Contact Information

Consumer Contact

Tags

View original FDA announcement